Synopsis:- A high-stakes battle is underway for a 60.72% stake in a major public sector bank, with final bids submitted after a two-year process. The Centre aims to raise ₹80,000 crore in FY27, while regulatory approvals and an open offer for 5% minority shareholders...
Synopsis:- Group telecom stocks gained up to 5% after Q3FY26 results showed 20% top-line growth for the flagship entity and 82% earnings surge for its regional arm. ARPU improved to Rs 253, subscriber base reached 29 million, and EBITDA margins strengthened,...
SYNOPSIS: One of India’s leading shipbuilding yards posted strong Q3 FY26 results with double-digit revenue and profit growth, improved EBITDA margins, a robust Rs. 23,758 crore order book, along with a Rs. 7.5 interim dividend. Shares of one of India’s leading...
Synopsis:- Shares jumped 5% after strong Q3FY26 results, backed by 27% YoY growth and sharp margin expansion. EBITDA rose 63% with margins at 8%. Beauty and Fashion segments delivered robust GMV growth of 27% and 31%, while offline expansion reached 276 stores across...
Synopsys:- Shares gained after a French bank acquired 5.02 lakh shares worth ₹40.5 crore via a bulk deal, taking a 0.68% stake. The stock has surged 52% in five days and 11.82% this year. With ₹205 crore FY26 capex planned, expansion and modernisation remain key focus...
Synopsis:- Shares rose nearly 3% after Q3FY26 results showed 15% YoY revenue growth to ₹5,345 crore and 36% QoQ profit jump to ₹510 crore. Brokerages remain divided, with targets ranging from ₹4,350 to ₹5,000, citing margin sustainability and weak like-for-like growth...
Synopsis:- Five stocks will trade ex-dividend on February 6, 2026, after announcing interim payouts ranging from ₹0.20 to ₹16 per share. Dividend yields go up to 3.57%, with market capitalisations spanning ₹2,628 crore to ₹2.51 lakh crore, offering varied income...
Synopsis:- Shares jumped up to 4.4% after strong Q3FY26 results and a 3:1 bonus announcement. Revenue rose 26% YoY to ₹406 crore, while profit climbed 35% to ₹42 crore. Patient volumes grew 14%, supported by strong B2B growth and rising contribution from specialty...
Synopsis:- Brokerages maintain a ‘Buy’ stance with targets of ₹575 and ₹550, implying nearly 30% upside from ₹443.90. Q4 revenue rose 14% to ₹4,204 crore, while profit climbed 33% to ₹260 crore. OPM eased to 15%, even as global expansion and capacity additions support...
Synopsis:- Shares gained up to 4% after announcing plans for an NSE direct listing to enhance liquidity and investor participation. With a market cap of ₹1,345 crore, the company has completed 154 projects, served 50,000 families, and developed over 6 million square...
